These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32031890)

  • 1. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five.
    Chen X; Li H; Tian L; Li Q; Luo J; Zhang Y
    J Comput Biol; 2020 Sep; 27(9):1397-1406. PubMed ID: 32031890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of a New Series of Thiazolyl-pyrazoline Derivatives as Cholinesterase Inhibitors.
    Temel HE; Altintop MD; Özdemir A
    Turk J Pharm Sci; 2018 Dec; 15(3):333-338. PubMed ID: 32454678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection.
    O' Donovan DH; De Fusco C; Kuhnke L; Reichel A
    J Med Chem; 2023 Feb; 66(4):2347-2360. PubMed ID: 36752336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Drug-likeness Rules Apply to Oral Prodrugs?
    Protti ÍF; Rodrigues DR; Fonseca SK; Alves RJ; de Oliveira RB; Maltarollo VG
    ChemMedChem; 2021 May; 16(9):1446-1456. PubMed ID: 33471444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Going further than Lipinski's rule in drug design.
    Walters WP
    Expert Opin Drug Discov; 2012 Feb; 7(2):99-107. PubMed ID: 22468912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting the right compounds for screening: does Lipinski's Rule of 5 for pharmaceuticals apply to agrochemicals?
    Tice CM
    Pest Manag Sci; 2001 Jan; 57(1):3-16. PubMed ID: 11455629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eyes on Lipinski's Rule of Five: A New "Rule of Thumb" for Physicochemical Design Space of Ophthalmic Drugs.
    Karami TK; Hailu S; Feng S; Graham R; Gukasyan HJ
    J Ocul Pharmacol Ther; 2022; 38(1):43-55. PubMed ID: 34905402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating physiochemical properties of FDA-approved orally administered drugs.
    Reese TC; Devineni A; Smith T; Lalami I; Ahn JM; Raj GV
    Expert Opin Drug Discov; 2024 Feb; 19(2):225-238. PubMed ID: 37921049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption matters: A closer look at popular oral bioavailability rules for drug approvals.
    Caminero Gomes Soares A; Marques Sousa GH; Calil RL; Goulart Trossini GH
    Mol Inform; 2023 Nov; 42(11):e202300115. PubMed ID: 37550251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rule of five violations among the FDA-approved small molecule protein kinase inhibitors.
    Roskoski R
    Pharmacol Res; 2023 May; 191():106774. PubMed ID: 37075870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview about the impact of hinge region towards the anticancer binding affinity of the Ck2 ligands: a quantum chemical analysis.
    Deepa P; Thirumeignanam D; Kolandaivel P
    J Biomol Struct Dyn; 2019 Sep; 37(15):3859-3876. PubMed ID: 30301411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiochemical property space distribution among human metabolites, drugs and toxins.
    Khanna V; Ranganathan S
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S10. PubMed ID: 19958509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-[(2-arylthiazol-4-yl)methyl]azoles as a new class of anticonvulsants: design, synthesis, in vivo screening, and in silico drug-like properties.
    Ahangar N; Ayati A; Alipour E; Pashapour A; Foroumadi A; Emami S
    Chem Biol Drug Des; 2011 Nov; 78(5):844-52. PubMed ID: 21827633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for low aquatic bioaccumulation. 1. Lipinski's 'Rule of 5' and molecular size.
    Nendza M; Müller M
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):495-512. PubMed ID: 20818584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
    Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Framework to Predict Uptake of Trace Organic Compounds by Plants.
    Kumar K; Gupta SC
    J Environ Qual; 2016 Mar; 45(2):555-64. PubMed ID: 27065403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of blockbuster drugs under the rule-of-five.
    Giménez BG; Santos MS; Ferrarini M; Fernandes JP
    Pharmazie; 2010 Feb; 65(2):148-52. PubMed ID: 20225662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties.
    Over B; McCarren P; Artursson P; Foley M; Giordanetto F; Grönberg G; Hilgendorf C; Lee MD; Matsson P; Muncipinto G; Pellisson M; Perry MW; Svensson R; Duvall JR; Kihlberg J
    J Med Chem; 2014 Mar; 57(6):2746-54. PubMed ID: 24524242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.